Alantolactone alleviates collagen-induced arthritis and inhibits Th17 cell differentiation through modulation of STAT3 signalling

References

• Aithal GP. 2011. Hepatotoxicity related to antirheumatic drugs. Nat Rev Rheumatol. 7(3):139–150.
   PubMed Web of Science ®Google Scholar
• Alvarez-Rodriguez L, Martinez-Taboada V, Calvo-Alen J, Beares I, Villa I, Lopez-Hoyos M. 2019. Altered Th17/Treg ratio in peripheral blood of systemic lupus erythematosus but not primary antiphospholipid syndrome. Front Immunol. 10:391.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. 2006. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature. 441(7090):235–238.
   PubMed Web of Science ®Google Scholar
• Brand DD, Latham KA, Rosloniec EF. 2007. Collagen-induced arthritis. Nat Protoc. 2(5):1269–1275.
   PubMed Web of Science ®Google Scholar
• Cantrell CL, Abate L, Fronczek FR, Franzblau SG, Quijano L, Fischer NH. 1999. Antimycobacterial eudesmanolides from Inula helenium and Rudbeckia subtomentosa. Planta Med. 65(4):351–355.
   PubMed Web of Science ®Google Scholar
• Caporali R, Caprioli M, Bobbio-Pallavicini F, Montecucco C. 2008. DMARDs and infections in rheumatoid arthritis. Autoimmun Rev. 8(2):139–143.
   PubMed Web of Science ®Google Scholar
• Chabaud M, Lubberts E, Joosten L, van Den Berg W, Miossec P. 2001. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res. 3(3):168–177.
   PubMedGoogle Scholar
• Chang D, Xing Q, Su Y, Zhao X, Xu W, Wang X, Dong C. 2020. The conserved non-coding sequences CNS6 and CNS9 control cytokine-induced Rorc transcription during T helper 17 cell differentiation. Immunity. 53(3):614–626.e4.
   PubMed Web of Science ®Google Scholar
• Chehata JC, Hassell AB, Clarke SA, Mattey DL, Jones MA, Jones PW, Dawes PT. 2001. Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity. Rheumatology (Oxford). 40(4):447–452.
   PubMed Web of Science ®Google Scholar
• Choy EH, Panayi GS. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 344(12):907–916.
   PubMed Web of Science ®Google Scholar
• Chun J, Choi RJ, Khan S, Lee DS, Kim YC, Nam YJ, Lee DU, Kim YS. 2012. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells. Int Immunopharmacol. 14(4):375–383.
   PubMed Web of Science ®Google Scholar
• Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. 1980. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 283(5748):666–668.
   PubMed Web of Science ®Google Scholar
• Crozier A, Jaganath IB, Clifford MN. 2009. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep. 26(8):1001–1043.
   PubMed Web of Science ®Google Scholar
• Deng GM, Zheng L, Chan FK, Lenardo M. 2005. Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors. Nat Med. 11(10):1066–1072.
   PubMed Web of Science ®Google Scholar
• Dhaouadi T, Chahbi M, Haouami Y, Sfar I, Abdelmoula L, Ben Abdallah T, Gorgi Y. 2018. IL-17a, IL-17rc polymorphisms and IL-17 plasma levels in Tunisian patients with rheumatoid arthritis. PLoS One. 13(3):e0194883.
   PubMed Web of Science ®Google Scholar
• Dos Passos GR, Sato DK, Becker J, Fujihara K. 2016. Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications. Mediators Inflamm. 2016:5314541.
   PubMed Web of Science ®Google Scholar
• Firestein GS. 2003. Evolving concepts of rheumatoid arthritis. Nature. 423(6937):356–361.
   PubMed Web of Science ®Google Scholar
• Gao S, Wang Q, Tian XH, Li HL, Shen YH, Xu XK, Wu GZ, Hu ZL, Zhang WD. 2017. Total sesquiterpene lactones prepared from Inula helenium L. has potentials in prevention and therapy of rheumatoid arthritis. J Ethnopharmacol. 196:39–46.
   PubMed Web of Science ®Google Scholar
• Gierlikowska B, Gierlikowski W, Bekier K, Skalicka-Woźniak K, Czerwińska ME, Kiss AK. 2020. Inula helenium and Grindelia squarrosa as a source of compounds with anti-inflammatory activity in human neutrophils and cultured human respiratory epithelium. J Ethnopharmacol. 249:112311.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gallego J, Garcia-Mediavilla MV, Sanchez-Campos S, Tunon MJ. 2010. Fruit polyphenols, immunity and inflammation. Br J Nutr. 104(Suppl. 3):S15–S27.
   PubMed Web of Science ®Google Scholar
• Hashimoto M. 2017. Th17 in animal models of rheumatoid arthritis. J Clin Med. 6(7):73.
   PubMed Web of Science ®Google Scholar
• Kelchtermans H, Schurgers E, Geboes L, Mitera T, Van Damme J, Van Snick J, Uyttenhove C, Matthys P. 2009. Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. Arthritis Res Ther. 11(4):R122.
   PubMed Web of Science ®Google Scholar
• Khan M, Li T, Ahmad Khan MK, Rasul A, Nawaz F, Sun M, Zheng Y, Ma T. 2013. Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction. Biomed Res Int. 2013:719858.
   PubMed Web of Science ®Google Scholar
• Kim KW, Kim HR, Kim BM, Cho ML, Lee SH. 2015. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis. Am J Pathol. 185(11):3011–3024.
   PubMed Web of Science ®Google Scholar
• Kim M, Song K, Kim YS. 2017. Alantolactone improves prolonged exposure of interleukin-6-induced skeletal muscle inflammation associated glucose intolerance and insulin resistance. Front Pharmacol. 8:405.
   PubMed Web of Science ®Google Scholar
• Kimura A, Naka T, Kishimoto T. 2007. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci U S A. 104(29):12099–12104.
   PubMed Web of Science ®Google Scholar
• Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, et al. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 103(9):1345–1352.
   PubMed Web of Science ®Google Scholar
• Kourbeti IS, Ziakas PD, Mylonakis E. 2014. Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis. Clin Infect Dis. 58(12):1649–1657.
   PubMed Web of Science ®Google Scholar
• Kunwar S, Dahal K, Sharma S. 2016. Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials. Rheumatol Int. 36(8):1065–1075.
   PubMed Web of Science ®Google Scholar
• Li S, Yin H, Zhang K, Wang T, Yang Y, Liu X, Chang X, Zhang M, Yan X, Ren Y, et al. 2017. Effector T helper cell populations are elevated in the bone marrow of rheumatoid arthritis patients and correlate with disease severity. Sci Rep. 7(1):4776.
   PubMedGoogle Scholar
• Lim HS, Jin SE, Kim OS, Shin HK, Jeong SJ. 2015. Alantolactone from Saussurea lappa exerts antiinflammatory effects by inhibiting chemokine production and stat1 phosphorylation in TNF-α and IFN-γ-induced in HaCaT cells. Phytother Res. 29(7):1088–1096.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu M, Wang S, He Y, Huo Y, Yang Z, Cao X. 2018. Alantolactone induces apoptosis and suppresses migration in MCF-7 human breast cancer cells via the p38 MAPK, NF-κB and Nrf2 signaling pathways. Int J Mol Med. 42(4):1847–1856.
   PubMed Web of Science ®Google Scholar
• Liu RH. 2013. Dietary bioactive compounds and their health implications. J Food Sci. 78(Suppl. 1):A18–A25.
   PubMed Web of Science ®Google Scholar
• Martin C, Butelli E, Petroni K, Tonelli C. 2011. How can research on plants contribute to promoting human health? Plant Cell. 23(5):1685–1699.
   PubMed Web of Science ®Google Scholar
• Maryam A, Mehmood T, Zhang H, Li Y, Khan M, Ma T. 2017. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress. Sci Rep. 7(1):6242.
   PubMedGoogle Scholar
• Mazor RL, Menendez IY, Ryan MA, Fiedler MA, Wong HR. 2000. Sesquiterpene lactones are potent inhibitors of interleukin 8 gene expression in cultured human respiratory epithelium. Cytokine. 12(3):239–245.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 7(6):429–442.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. 2011. The pathogenesis of rheumatoid arthritis. N Engl J Med. 365(23):2205–2219.
   PubMed Web of Science ®Google Scholar
• Mills KH. 2008. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol. 38(10):2636–2649.
   PubMed Web of Science ®Google Scholar
• Morinobu A, Biao W, Tanaka S, Horiuchi M, Jun L, Tsuji G, Sakai Y, Kurosaka M, Kumagai S. 2008. (–)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice. Arthritis Rheum. 58(7):2012–2018.
   PubMedGoogle Scholar
• Parsonage G, Filer A, Bik M, Hardie D, Lax S, Howlett K, Church LD, Raza K, Wong SH, Trebilcock E, et al. 2008. Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha. Arthritis Res Ther. 10(2):R47.
   PubMed Web of Science ®Google Scholar
• Qin H, Wang L, Feng T, Elson CO, Niyongere SA, Lee SJ, Reynolds SL, Weaver CT, Roarty K, Serra R, et al. 2009. TGF-beta promotes Th17 cell development through inhibition of SOCS3. J Immunol. 183(1):97–105.
   PubMed Web of Science ®Google Scholar
• Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, Lord JM, Gordon C, Buckley CD, Salmon M. 2005. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther. 7(4):R784–R795.
   PubMed Web of Science ®Google Scholar
• Rios JL, Recio MC, Escandell JM, Andujar I. 2009. Inhibition of transcription factors by plant-derived compounds and their implications in inflammation and cancer. Curr Pharm Des. 15(11):1212–1237.
   PubMed Web of Science ®Google Scholar
• Roeleveld DM, Koenders MI. 2015. The role of the Th17 cytokines IL-17 and IL-22 in rheumatoid arthritis pathogenesis and developments in cytokine immunotherapy. Cytokine. 74(1):101–107.
   PubMed Web of Science ®Google Scholar
• Seca AM, Grigore A, Pinto DC, Silva AM. 2014. The genus Inula and their metabolites: from ethnopharmacological to medicinal uses. J Ethnopharmacol. 154(2):286–310.
   PubMed Web of Science ®Google Scholar
• Seo JY, Lim SS, Kim JR, Lim JS, Ha YR, Lee IA, Kim EJ, Park JH, Kim JS. 2008. Nrf2-mediated induction of detoxifying enzymes by alantolactone present in Inula helenium. Phytother Res. 22(11):1500–1505.
   PubMed Web of Science ®Google Scholar
• Shen H, Goodall JC, Hill Gaston JS. 2009. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 60(6):1647–1656.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, et al. 2018. Rheumatoid arthritis. Nat Rev Dis Primers. 4:18001.
   PubMed Web of Science ®Google Scholar
• Stockinger B, Veldhoen M. 2007. Differentiation and function of Th17 T cells. Curr Opin Immunol. 19(3):281–286.
   PubMed Web of Science ®Google Scholar
• Stojanovic-Radic Z, Comic L, Radulovic N, Blagojevic P, Denic M, Miltojevic A, Rajkovic J, Mihajilov-Krstev T. 2012. Antistaphylococcal activity of Inula helenium L. Root essential oil: eudesmane sesquiterpene lactones induce cell membrane damage. Eur J Clin Microbiol Infect Dis. 31(6):1015–1025.
   PubMed Web of Science ®Google Scholar
• Tan L, Li J, Wang Y, Tan R. 2019. Anti-neuroinflammatory effect of alantolactone through the suppression of the NF-κB and MAPK signaling pathways. Cells. 8:739.
   PubMed Web of Science ®Google Scholar
• Teixeira Damasceno NR, Apolinario E, Dias Flauzino F, Fernandes I, Abdalla DS. 2007. Soy isoflavones reduce electronegative low-density lipoprotein (LDL−) and anti-LDL− autoantibodies in experimental atherosclerosis. Eur J Nutr. 46(3):125–132.
   PubMed Web of Science ®Google Scholar
• Van Bezooijen RL, Van Der Wee-Pals L, Papapoulos SE, Lowik CW. 2002. Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro. Ann Rheum Dis. 61(10):870–876.
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 24(2):179–189.
   PubMed Web of Science ®Google Scholar
• Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. 2009. IL-17 can promote tumor growth through an IL-6-STAT3 signaling pathway. J Exp Med. 206(7):1457–1464.
   PubMed Web of Science ®Google Scholar
• Wang Q, Gao S, Wu GZ, Yang N, Zu XP, Li WC, Xie N, Zhang RR, Li CW, Hu ZL, et al. 2018. Total sesquiterpene lactones isolated from Inula helenium L. attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice. Phytomedicine. 46:78–84.
   PubMed Web of Science ®Google Scholar
• Wang X, Lan YL, Xing JS, Lan XQ, Wang LT, Zhang B. 2018. Alantolactone plays neuroprotective roles in traumatic brain injury in rats via anti-inflammatory, anti-oxidative and anti-apoptosis pathways. Am J Transl Res. 10(2):368–380.
   PubMed Web of Science ®Google Scholar
• Yang J, Sundrud MS, Skepner J, Yamagata T. 2014. Targeting Th17 cells in autoimmune diseases. Trends Pharmacol Sci. 35(10):493–500.
   PubMed Web of Science ®Google Scholar
• Zheng H, Yang L, Kang Y, Chen M, Lin S, Xiang Y, Li C, Dai X, Huang X, Liang G, et al. 2019. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling. Mol Carcinog. 58(4):565–576.
   PubMed Web of Science ®Google Scholar
• Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 8(9):967–974.
   PubMed Web of Science ®Google Scholar
• Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, Maslinski W. 2000. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol. 164(5):2832–2838.
   PubMed Web of Science ®Google Scholar
• Zrioual S, Ecochard R, Tournadre A, Lenief V, Cazalis MA, Miossec P. 2009. Genome-wide comparison between IL-17a- and IL-17f-induced effects in human rheumatoid arthritis synoviocytes. J Immunol. 182(5):3112–3120.
   PubMed Web of Science ®Google Scholar
• Zuo L, Zhou T, Pannell BK, Ziegler AC, Best TM. 2015. Biological and physiological role of reactive oxygen species—the good, the bad and the ugly. Acta Physiol (Oxf). 214(3):329–348.
   PubMed Web of Science ®Google Scholar